<DOC>
	<DOCNO>NCT00967681</DOCNO>
	<brief_summary>The purpose study evaluate whether Oncoxin , nutritional supplement , improve clinical ultrasonographic result comparison placebo 24 week treatment .</brief_summary>
	<brief_title>Efficacy Safety ONCOXIN Patients With Breast Fibrocystic Disease</brief_title>
	<detailed_description />
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Fibrocystic Breast Disease</mesh_term>
	<criteria>Patients clinical ultrasonographic confirmation breast fibrocystic disease . Patients older 20 year . Female patient . Informed consent . Presents another disease well control . Pregnant woman lactate . Patient receive another product investigation trial .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>